|
|
| 45.03 Real-Time Quote |  +0.53 / +1.20%Today’s Change | 41.52 Today|||52-Week Range 57.34 | -4.36% Year-to-Date |
| Coverage Initiated on ResMed - Analyst Blog Mar 11 / Zacks.com | Insider Trading Alert - QEP, PKG And RMD Traded By Insiders Mar 05 / TheStreet.com |
| ResMed Inc (RMD): New Analyst Report from Zacks Equity Research - Zacks Equity Resear... Mar 10 / Zacks.com |
| Previous close | 44.49 |
| Today’s open | 44.66 |
| Day’s range | 44.58 - 45.45 |
| Volume | 440,896 |
| Average volume (3 months) | 1,220,753 |
| Market cap | $6.3B |
| Dividend yield | 2.22% |
| Earnings growth (last year) | +22.81% |
| Earnings growth (this year) | +9.82% |
| Earnings growth (next 5 years) | +12.50% |
| Revenue growth (last year) | +10.66% |
| P/E ratio | 20.2 |
| Price/Sales | 4.26 |
| Price/Book | 3.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| TFXTeleflex Inc | +0.32 | +0.31% |
| VARVarian Medical Syste... | -0.02 | -0.02% |
| PCRXPacira Pharmaceutica... | -0.74 | -1.00% |
| THORThoratec Corp | -1.31 | -3.66% |
| Next reporting date | April 24, 2014 |
| EPS forecast (this quarter) | $0.64 |
| Annual revenue (last year) | $1.5B |
| Annual profit (last year) | $307.1M |
| Net profit margin | 20.28% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director Michael J. Farrell |
President & Chief Operating Officer Robert Andrew Douglas |
Corporate headquarters San Diego, California |
.
